Barotrauma
10
3
3
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
Diagnostic Precision and Accuracy Using the Teed Scoring System Versus the O'Neill Grading System
Barotrauma in Hyperbaric Oxygen Therapy
Laboratory Biomarkers and Pulmonary Interstitial Emphysema in ARDS (PIE-ARDS)
Imaging Biomarkers to Stratify the Risk of Barotrauma in ARDS
"Barotrauma in Admitted Covid-19 Cases - A Single Center Retrospective Study"
Barotrauma in Adults With Critical COVID-19
Lung Damage Caused by SARS-CoV-2 Pneumonia (COVID-19)
Risk Factors for Barotrauma in COVID-19
Comparison of Primary Extubation Failure Between NIPPV and NI-NAVA
The Ornge Comparison of Tracheal Occlusion Pressures to Ensure Safety Trial